Table 4.

Sequence determination of clonal antigen receptor gene rearrangements in patient ALL-7 at time of diagnosis, relapse, and following tertiary engraftment in NOD/SCID mice


Rearrangement

Sequence
IGH  
    Diagnosis   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
    Relapse   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
    NOD/SCID 3°   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
IGK-Kde  
    Diagnosis   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
    Relapse   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
    NOD/SCID 3°   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
IGK-Kde  
    Diagnosis   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
    Relapse   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
    NOD/SCID 3°   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
IGK-intron Kde  
    Diagnosis   (VκIntron)CAGCTTTCC...............................GG...............................GGGAGCCCTA (Kde)  
    Relapse   Clonal rearrangement lost  
    NOD/SCID 3°   Clonal rearrangement lost  
TCRG  
    Diagnosis   (VγGCGTGGG..................................TTGTC..................................GAATTATTAT (Jγ)  
    Relapse   (VγCTGGGAC...............................TCGCCGAGGGG...............................ATTATAAGAA (Jγ)  
    NOD/SCID 3°
 
(VγCTGGGAC...............................TCGCCGAGGGG...............................ATTATAAGAA (Jγ)
 

Rearrangement

Sequence
IGH  
    Diagnosis   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
    Relapse   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
    NOD/SCID 3°   (VH4-39)CGAGAC..................CTCTAGGATATTGTAGTGGTGGTAGCTGCTAGG..................CTGGTTCGAC (JH5)  
IGK-Kde  
    Diagnosis   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
    Relapse   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
    NOD/SCID 3°   (Vκ3-20)CTCACCT.................................CC.................................AGCCCTAGT (Kde)  
IGK-Kde  
    Diagnosis   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
    Relapse   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
    NOD/SCID 3°   (Vκ3-20)AGCTCACCT...............................GCC...............................GGAGCCCTAGT (Kde)  
IGK-intron Kde  
    Diagnosis   (VκIntron)CAGCTTTCC...............................GG...............................GGGAGCCCTA (Kde)  
    Relapse   Clonal rearrangement lost  
    NOD/SCID 3°   Clonal rearrangement lost  
TCRG  
    Diagnosis   (VγGCGTGGG..................................TTGTC..................................GAATTATTAT (Jγ)  
    Relapse   (VγCTGGGAC...............................TCGCCGAGGGG...............................ATTATAAGAA (Jγ)  
    NOD/SCID 3°
 
(VγCTGGGAC...............................TCGCCGAGGGG...............................ATTATAAGAA (Jγ)
 

Randomly inserted bases are shown in bold. Underlined bases present in the IGH rearranged sequence indicate a D2-15 segment. The particular V and J segments present in each rearrangement are shown in parentheses. VκIntron refers to an intronic segment of kappa light chain between Jκ5 and Cκ. Kde refers to the kappa deleting element.

or Create an Account

Close Modal
Close Modal